GLP-1 drugs out-earn OpenAI and Anthropic combined, pulling labs into biotech
Alex Colville of Age1 covers the four-part framework for aging interventions, why AI labs are moving into biotech, and why China, not AI, has reshaped drug development.
Loading articles…
The complete subject coverage could not load. Published articles remain below.